A chart shows the different trajectories of Moderna's stock versus shares of the XBI biotech index since the start of 2024. Moderna's share price forms almost a U-shape for most of this time, rising significantly on Aug. 19, 2026 because of its cancer vaccine data. The XBI, meanwhile, steadily rose over much of the period.